4Filed Aug 6, 8:00 PM ET

Johnson & Johnson (JNJ) CEO Joaquin Duato Sells 48,480 Shares

$JNJ · JOHNSON & JOHNSON

Research Summary

AI-generated summary of this SEC filing

Updated

Johnson & Johnson (JNJ) CEO Joaquin Duato Sells 48,480 Shares

What Happened
Joaquin Duato, CEO and Chairman of Johnson & Johnson, sold a total of 48,480 JNJ shares in open-market transactions on August 5, 2026. The sales consisted of 41,957 shares at a weighted-average price of $258.06 (total $10,827,256) and 6,523 shares at a weighted-average price of $258.74 (total $1,687,754), for aggregate proceeds of $12,515,010. These were outright sales (code S) — routine dispositions rather than purchases.

Key Details

  • Transaction date: August 5, 2026; Form 4 filed August 7, 2026 (timely — within the typical two-business-day filing window).
  • Reported weighted-average prices: $258.06 (for the 41,957-share lot) and $258.74 (for the 6,523-share lot).
  • Price ranges per footnotes: first lot executed between $257.53–$258.505; second lot between $258.535–$259.10. The filing gives weighted averages and offers to provide per-trade details on request.
  • Shares owned after transaction: not specified in the provided excerpt of the filing; the filing notes holdings include shares accrued via dividend reinvestment in the Johnson & Johnson Stock Fund under the company Savings Plan as of 7/31/2026. (See footnote re: dividend reinvestment.)
  • Transaction type: Open-market sales (S). No option exercise, grant, or gift involved.

Context

  • Sales by executives can be for many routine reasons (diversification, liquidity, tax planning) and do not by themselves indicate a change in company outlook. Purchases generally carry more signal for positive insider sentiment.
  • There is no indication in this filing of derivative activity (exercises) or automatic plans (e.g., 10b5‑1) noted in the provided details.